Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS.

Am J Gastroenterol. 2009 Apr;104(4):1033-49; quiz 1050. doi: 10.1038/ajg.2009.25. Epub 2009 Mar 10. Review.

PMID:
19277023
2.

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM.

Gut. 2010 Mar;59(3):325-32. doi: 10.1136/gut.2008.167270. Epub 2008 Dec 17. Review.

PMID:
19091823
3.

Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.

Brenner DM, Chey WD.

Rev Gastroenterol Disord. 2009 Winter;9(1):7-15. Review.

PMID:
19367213
4.

Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

Bixquert Jiménez M.

Rev Esp Enferm Dig. 2009 Aug;101(8):553-64. Review.

5.

Review article: probiotics and prebiotics in irritable bowel syndrome.

Spiller R.

Aliment Pharmacol Ther. 2008 Aug 15;28(4):385-96. doi: 10.1111/j.1365-2036.2008.03750.x. Epub 2008 Jun 4. Review.

6.

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.

Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P.

BMC Gastroenterol. 2009 Feb 16;9:15. doi: 10.1186/1471-230X-9-15. Review.

7.

Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective.

Tack J, Fried M, Houghton LA, Spicak J, Fisher G.

Aliment Pharmacol Ther. 2006 Jul 15;24(2):183-205. Review.

8.

Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.

Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J.

Curr Med Res Opin. 2017 Jul;33(7):1191-1197. doi: 10.1080/03007995.2017.1292230. Epub 2017 Mar 7. Review.

PMID:
28166427
9.

Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.

Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S214-7. doi: 10.1097/MCG.0b013e31817da129. Review.

PMID:
18685517
10.

Effectiveness of probiotics in the treatment of irritable bowel syndrome.

Wilhelm SM, Brubaker CM, Varcak EA, Kale-Pradhan PB.

Pharmacotherapy. 2008 Apr;28(4):496-505. doi: 10.1592/phco.28.4.496. Review.

PMID:
18363533
11.

Use of diet and probiotic therapy in the irritable bowel syndrome: analysis of the literature.

Floch MH.

J Clin Gastroenterol. 2005 May-Jun;39(5 Suppl 3):S243-6. Review.

PMID:
15798491
12.

Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.

Camilleri M.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S123-5. doi: 10.1097/MCG.0b013e3181574393. Review.

PMID:
18806702
13.
14.

Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.

Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P.

Am J Gastroenterol. 2009 Jul;104(7):1831-43; quiz 1844. doi: 10.1038/ajg.2009.223. Epub 2009 May 26. Review.

PMID:
19471254
15.

Review article: the treatment of functional abdominal bloating and distension.

Schmulson M, Chang L.

Aliment Pharmacol Ther. 2011 May;33(10):1071-86. doi: 10.1111/j.1365-2036.2011.04637.x. Epub 2011 Mar 29. Review.

16.

The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.

Ringel Y, Ringel-Kulka T.

J Clin Gastroenterol. 2011 Nov;45 Suppl:S145-8. doi: 10.1097/MCG.0b013e31822d32d3. Review.

PMID:
21992954
17.

Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome--a European perspective.

Heading R, Bardhan K, Hollerbach S, Lanas A, Fisher G.

Aliment Pharmacol Ther. 2006 Jul 15;24(2):207-36. Review.

18.

[Probiotic therapy of the irritable bowel syndrome].

Enck P, Klosterhalfen S, Martens U.

Dtsch Med Wochenschr. 2011 Feb;136(8):371-5. doi: 10.1055/s-0031-1272538. Epub 2011 Feb 17. Review. German.

PMID:
21332036
19.

Probiotics in irritable bowel syndrome: an immunomodulatory strategy?

Quigley EM.

J Am Coll Nutr. 2007 Dec;26(6):684S-90S. Review.

PMID:
18187434
20.

Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.

Guilera M, Balboa A, Mearin F.

Am J Gastroenterol. 2005 May;100(5):1174-84. Review.

PMID:
15842596

Supplemental Content

Support Center